Top
image credit: Freepik

Britain bets on biotech as billions set to boost life sciences sector

July 8, 2021

Category:

British Patient Capital, the commercial arm of the U.K. government’s British Business Bank, is kickstarting the program, funneling £200 million to “specialist funds” designed to “unlock the potential of innovative U.K. life sciences companies so that they can grow their operations and create high-skilled jobs in the U.K.,” according to the government.

“The program will leverage further private sector investment and support the development of a world-leading U.K, life sciences venture capital,” the statement said.

Read More on FierceBiotech